Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
$29.11
+4.90%today
MKT CAP
$1.7B
+5.8% · 1Y
Earnings History
-71.1%
-9.3%
+22.3%
-2.1%
Q1 '25
Q2 '25
Q3 '25
Q4 '25
Analyst Targets
Current price
$29.11
Low
$38.20
Analyst Mean
$48.08
High
$56.58
10 analystsStrong Buy
Full Financials
Trailing P/E-
Forward P/E-14.4x
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ+69.1%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership4.3%
Institutional Ownership43.6%
Short % of Float0.86%
Days to Cover2.1d
1 Week+3.9%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Eqt Fund Management S.a R.l. | institution | 10.18% | $0.17B | +0.00% | 2025-12-31 |
| Gildi - Lifeyrissjodur | institution | 4.19% | $0.07B | -0.72% | 2026-03-31 |
| Pivotal bioVenture Partners Investment Advisor, LLC | institution | 3.95% | $0.07B | -0.53% | 2025-12-31 |
| Aberdeen Group plc | institution | 3.01% | $0.05B | +0.00% | 2026-03-31 |
| Wellington Management Group, LLP | institution | 2.34% | $0.04B | +100.00% | 2025-12-31 |
| SR One Capital Management, LP | institution | 1.11% | $0.02B | +98.77% | 2025-12-31 |
| abrdn Healthcare Investors | fund | 1.00% | $0.02B | +42.39% | 2025-12-31 |
| abrdn Healthcare Opportunities Fund | fund | 0.98% | $0.02B | +33.62% | 2025-12-31 |
| Nan Fung Group Holdings Limited | institution | 0.89% | $0.01B | +0.00% | 2025-12-31 |
| Saturn V Capital Management LP | institution | 0.89% | $0.01B | +100.00% | 2025-12-31 |
| Perceptive Advisors Llc | institution | 0.85% | $0.01B | +100.00% | 2025-12-31 |
| abrdn World Healthcare Fund | fund | 0.59% | $0.01B | +38.09% | 2025-12-31 |
| Alyeska Investment Group, L.p. | institution | 0.57% | $0.01B | +152.29% | 2025-12-31 |
| abrdn Life Sciences Investors | fund | 0.44% | $0.01B | +48.68% | 2025-12-31 |
| HARTFORD MUTUAL FUNDS INC/CT-THE HARTFORD HEALTHCARE FUND | fund | 0.32% | $0.01B | +0.00% | 2026-01-31 |
| Global Macro Absolute Return Advantage Portfolio | fund | 0.19% | $0.00B | +236.46% | 2026-01-31 |
| VANGUARD WHITEHALL FUNDS-Vanguard International Explorer Fund | fund | 0.18% | $0.00B | +0.00% | 2026-01-31 |
| Simplify Exchange Traded Funds-Simplify Propel Opportunities ETF | fund | 0.17% | $0.00B | +100.00% | 2025-12-31 |
| ALPS ETF TRUST-ALPS Medical Breakthroughs ETF | fund | 0.09% | $0.00B | +100.00% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.06% | $0.00B | +0.00% | 2026-02-28 |
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for OCS.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.